The Linked Clinical Trials initiative (LCT) for Parkinson's disease
Author:
Affiliation:
1. Center for Neurodegenerative Science; Van Andel Research Institute; Grand Rapids Michigan
2. The Cure Parkinson's Trust; London UK
Funder
Cure Parkinson’s Trust
Michael J Fox Foundation
JP Moulton Charitable Foundation
Horizon 2020 Framework Programme
Publisher
Wiley
Subject
General Neuroscience
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejn.14175/fullpdf
Reference21 articles.
1. Insulin resistance and Parkinson's disease: A new target for disease modification?;Athauda;Progress in Neurobiology,2016
2. Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease;Athauda;Neuropharmacology,2018
3. Post hoc analysis of the exenatide-PD trial - factors that predict response;Athauda;European Journal of Neuroscience,2018
4. What effects might exenatide have on non-motor symptoms in Parkinson's disease: A post hoc analysis;Athauda;Journal of Parkinson's Disease,2018
5. Exenatide once weekly versus placebo in Parkinson's disease: A randomised, double-blind, placebo-controlled trial;Athauda;Lancet (London, England),2017
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease;Movement Disorders;2024-06-26
2. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative;Journal of Parkinson's Disease;2024-06-04
3. Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol;BMJ Open;2023-12
4. Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D;Pharmaceutical Medicine;2022-08-12
5. Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update;Journal of Parkinson's Disease;2022-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3